We outline the market outlook for diabetes digital therapeutics in healthcare — from investment trends, to leading companies, to recommendations for players in the space.
What are diabetes digital therapeutics?
Companies in this space develop digital therapeutics (DTx) to help prevent, manage, or treat diabetes (type 1 and type 2). Several startups in this category offer digital apps that leverage evidence-based behavior change strategies, such as cognitive behavioral therapy (CBT), to help individuals manage and improve their diet and lifestyle choices. Additionally, some companies pair continuous glucose monitors, insulin delivery systems, and smart scales with their digital apps.